About Renovos
Renovos is a company based in Southampton (United Kingdom) founded in 2017 by Agnieszka Janeczek, Richard Oreffo, Jonathan Dawson, and James Otter. It operates as a HealthTech. Renovos has raised $182.91 thousand across 4 funding rounds from investors including Biocomposites, UK Research and Innovation and Henley Business Angels. Renovos offers products and services including RENOVITE®. Renovos operates in a competitive market with competitors including Kerecis, Kuros Biosciences, OssDsign, Sofregen and Cerapedics, among others.
- Headquarter Southampton, United Kingdom
- Founders Agnieszka Janeczek, Richard Oreffo, Jonathan Dawson, James Otter
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Renovos Biologics Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$182.91 K (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Biocomposites
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Renovos
Renovos offers a comprehensive portfolio of products and services, including RENOVITE®.
A nanoclay platform for precise therapeutic delivery solutions.
Funding Insights of Renovos
Renovos has successfully raised a total of $182.91K across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Renovos
Renovos has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Biocomposites, UK Research and Innovation and Henley Business Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A network of investors and entrepreneurs is facilitated by Henley Business Angels.
|
Locked | Locked | Locked | |
|
Synthetic calcium composites are developed for bone repair and regeneration.
|
Locked | Locked | Locked | |
|
Research and innovation funding is managed for UK advancement.
|
Locked | Locked | Locked |
Investor details for Renovos
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Renovos
Investment portfolio details for Renovos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Renovos
Detailed financials for Renovos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Renovos Comparisons
Peer comparison for Renovos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Renovos
Renovos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Kuros Biosciences, OssDsign, Sofregen and Cerapedics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| Locked | Locked | Locked |
Provider of smart solutions for bone disease management
|
|
| Locked | Locked | Locked |
Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma
|
|
| Locked | Locked | Locked |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| Locked | Locked | Locked |
Osteobiologic products are developed using synthetic peptide technology.
|
|
| Locked | Locked | Locked |
Developer of treatments for cartilage and bone problems
|
Detailed competitors of Renovos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Renovos
Complete news archive for Renovos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renovos
Renovos was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Renovos is headquartered in Southampton, United Kingdom.
Renovos is a funded company, having raised a total of $182.91K across 4 funding rounds to date.
Renovos is engaged in developing advanced regenerative medicine solutions through its proprietary RENOVITE nanoclay technology platform. This platform is utilized as an injectable scaffold to host regenerative cells and template new tissue formation. It is designed to localize and retain biologics for safer and more efficient applications at reduced doses. The company addresses unmet clinical needs in tissue regeneration, targeting age-related diseases and trauma in both aging and active populations. Solutions are aimed at providing economic benefits to health systems and improved outcomes for patients to support active living and healthy aging.
Renovos's top competitors include Kerecis, BONESUPPORT and OssDsign.
Renovos offers RENOVITE®.
Renovos has 4 investors. Key investors include Biocomposites, UK Research and Innovation, Henley Business Angels, and Orthopaedic Research UK.